LncRNA SBF2-AS1 promotes the progression of cervical cancer by regulating miR-361-5p/FOXM1 axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30:1.
   PubMed Web of Science ®Google Scholar
• Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Canadian Med Assoc J. 2001;164:1017–1025.
   PubMed Web of Science ®Google Scholar
• Reynoso-Noverón N, Peña-Nieves A, Rodríguez MO, et al. Cervical cancer epidemiology: cervical cancer. Cham: Springer; 2017. p. 19–33.
   Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15:7.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–166.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun G, Zhang H, et al. Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 2017;85:511–516.
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun G, Zhang H, et al. Long non-coding RNA PVT1 facilitates cervical cancer progression through negative modulation of miR-128-3p. Int J Clin Exp Pathol. 2017;10:4522–4529.
   Web of Science ®Google Scholar
• Guo H, Yang S, Li S, et al. LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer. Biomed Pharmacother. 2018;102:749–757.
   PubMed Web of Science ®Google Scholar
• Zhao QS, Li L, Zhang L, et al. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2016;20:3031–3034.
   PubMed Web of Science ®Google Scholar
• Lv J, Qiu M, Xia W, et al. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer. J Exp Clin Cancer Res. 2016;35:75.
   PubMed Web of Science ®Google Scholar
• Zhang YT, Li BP, Zhang B, et al. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Eur Rev Med Pharmacol Sci. 2018;22:6333–6341.
   PubMed Web of Science ®Google Scholar
• Chen R, Xia W, Wang X, et al. Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma. Oncol Lett. 2018;15:5071–5080.
   PubMed Web of Science ®Google Scholar
• Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016;1859:169–176.
   PubMed Web of Science ®Google Scholar
• Hou XW, Sun X, Yu Y, et al. miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. Neoplasma 2017;64:526–534.
   PubMed Web of Science ®Google Scholar
• Tian L, Zhao Z, Xie L, et al. MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway. Oncotarget. 2018;9:4886.
   PubMedGoogle Scholar
• Zhang H, Yang F, Chen SJ, et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol. 2015;36:2947–2955.
   PubMedGoogle Scholar
• Gao K, Ji Z, She K, et al. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway. Biomed Pharmacother. 2017;87:555–560.
   PubMed Web of Science ®Google Scholar
• Wang A, Jin C, Li H, et al. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway. Int J Biol Macromol. 2018;120:1705–1713.
   PubMed Web of Science ®Google Scholar
• Zhang S, Dong X, Ji T, et al. Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. Am J Transl Res. 2017;9:366.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang W, Cao L, et al. Long non-coding RNA CCAT1 acts as a competing endogenous RNA to regulate cell growth and differentiation in acute myeloid leukemia. Mol Cells. 2016;39:330.
   PubMed Web of Science ®Google Scholar
• Myatt SS, Lam EWF. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7:847.
   PubMed Web of Science ®Google Scholar
• Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta. 2007;1775:92–102.
   PubMed Web of Science ®Google Scholar
• Luo W, Gao F, Li S, et al. FoxM1 promotes cell proliferation, invasion, and stem cell properties in nasopharyngeal carcinoma. Front Oncol. 2018;8:483.
   PubMed Web of Science ®Google Scholar
• Wang L, Lu J, Zhang H, et al. MicroRNA-876-5p inhibits the progression of glioblastoma multiforme by directly targeting Forkhead box M1. Oncol Rep. 2019;41:702–710.
   PubMed Web of Science ®Google Scholar